Journey Medical (DERM) Gross Profit (2020 - 2026)

Journey Medical has reported Gross Profit for 7 years, with the latest figure at $9.7 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 16.22% year-over-year to $9.7 million; the trailing twelve-month figure through Mar 2026 stood at $41.7 million (up 13.96% YoY), and the FY2025 full-year result was $40.9 million, up 16.11% from the prior year.
• Gross Profit for Q1 2026 stood at $9.7 million, down from $10.6 million in the prior quarter.
• The five-year high for Gross Profit was $12.6 million in Q1 2022, with the low at -$6.5 million in Q4 2023.
• Historically, Gross Profit has averaged $8.6 million across 5 years, with a median of $9.4 million in 2023.
• Annual changes were most pronounced in 2023 — Gross Profit tumbled 159.85% — and 2024, when it surged 237.33%.
• Journey Medical's Gross Profit stood at $10.9 million in 2022, then plunged by 159.85% to -$6.5 million in 2023, then surged by 237.33% to $8.9 million in 2024, then climbed by 19.0% to $10.6 million in 2025, then dropped by 8.8% to $9.7 million in 2026.
• The last three Gross Profit figures came in at $9.7 million (Q1 2026), $10.6 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.